Blog

Top 5 Takeaways Lower Incidence with Masks: Districts with universal mask requirements had a 23% lower incidence of COVID-19 among staff and students compared to those without mask mandates. Impact

Top 5 Takeaways Prevalence of Long-Term Symptoms: Approximately two-thirds of respondents with a positive SARS-CoV-2 test experienced long-term symptoms, compared to 42.9% of those with a negative test. Common Long-Term

Top 5 Takeaways Full FDA Approval: On January 31, 2022, the FDA granted full approval to the Moderna COVID-19 vaccine for individuals aged ≥18 years. ACIP Recommendation: On February 4,

Top 5 Takeaways Vaccine Effectiveness Decline: The overall age-adjusted vaccine effectiveness (VE) against new COVID-19 cases declined from 91.8% to 75.0% during May 3–July 25, 2021. Stable Hospitalization Protection: VE

Top 5 Takeaways Prevalence of Binge Drinking: In 2018, 16.6% of U.S. adults reported binge drinking in the past 30 days, representing approximately 38.5 million people. Demographic Variations: Binge drinking

Top 5 Takeaways High Provider Accessibility: By 11 weeks after the pediatric COVID-19 vaccination program launch, 92% of children aged 5–11 years lived within 5 miles of a vaccine provider.

Top 5 Takeaways Emerging Substance: Xylazine, a veterinary tranquilizer, is increasingly found in drug overdose deaths in Connecticut. Combination with Fentanyl: Nearly all xylazine-positive deaths also involved fentanyl, highlighting a

Top 5 Takeaways High Adverse Event Rate: 91.4% of patients reported experiencing at least one adverse event during treatment with nifurtimox. Demographic Concentration: Most patients were adults aged ≥18 years

Top 5 Takeaways Xylazine Detection: Xylazine was detected in 1.8% of overdose deaths reported to the State Unintentional Drug Overdose Reporting System (SUDORS) in 2019. Xylazine Involvement: Xylazine was listed